Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations

doi:10.3748/wjg.v12.i17.2742

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6469)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

616

HTML

5443

Figures (1-4)

251

Tables (1-2)

159

Sum=6469

May 7, 2006 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 7, 2006; 12(17): 2742-2748
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2742

Full Size Figure Download Figure

Figure 1 Chromatograms of spiked plasma sample (B), plasma samples of patients before (A) and after (C) the administration of 200 mg ranitidine. M1 and M2 are metabolites of ranitidine.

Citation: Zhou Q, Ruan ZR, Yuan H, Jiang B, Xu DH. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. World J Gastroenterol 2006; 12(17): 2742-2748
URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2742.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i17.2742